Riskpilot← Back to searchSign inGet full accessBIOBALANCE LABORATORIES AS
ASActiveOrg 984701683Holterkollveien 7A, 1448 DrøbakTechnical testing and analysis · NACE 7120Est. 20020 employees
Revenue 2019
NOK 2M
-68% vs 2018
EBITDA margin
-34.8%
-81% vs 2018
Equity ratio
-269.2%
Financial strength
Net profit 2019
NOK -717K
-80% vs 2018
| Revenue | NOK 2M | -68% |
| EBITDA | NOK -711K | -81% |
| Net profit | NOK -717K | -80% |
| Total assets | NOK 641K | -49% |
| Equity | NOK -1,7M | -71% |
| Employees | 0 | — |
Legal name
BIOBALANCE LABORATORIES AS
Org number
984701683
Legal form
Aksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
26. august 2002
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Forskning vedr. Desinfeksjon og bakterieresistens, analysering av hårprøver og blodprøver samt måling av bakterienivå på overflater og i vann, utarbeidelse av bakteriell tilstandsrapport.
Address
Holterkollveien 7A, 1448 Drøbak
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 336 | 1 555 | 202 | 0 | 0 | 0 | 0 | 7 012 | 11 | 2 770 | 6 454 | 2 041 |
| Staff expenses | −624 | −794 | −278 | −0 | −0 | −0 | −0 | −105 | −0 | −372 | −1 568 | −868 |
| EBITDA | −184 | −110 | −247 | −29 | −10 | 0 | 0 | 2 868 | −26 | −791 | −394 | −711 |
| Depreciation & amort. | −27 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −5 |
| EBIT | −211 | −110 | −247 | −29 | −10 | 0 | 0 | 2 868 | −26 | −791 | −394 | −716 |
| Net financials | 1 | −1 | −11 | 0 | 0 | 0 | 0 | 1 | 45 | −16 | −4 | −1 |
| Profit before tax | −210 | −111 | −257 | −29 | −10 | 0 | 0 | 2 868 | 19 | −807 | −398 | −717 |
| Tax | 33 | −0 | −0 | −0 | −0 | −0 | −0 | 576 | −0 | −0 | −0 | −0 |
| Net profit | −244 | −111 | −257 | −29 | −10 | 0 | 0 | 2 293 | 19 | −807 | −398 | −717 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 73 | 515 | 83 | 28 | 18 | 18 | 18 | 2 718 | 908 | 1 571 | 1 250 | 641 |
| Equity | −109 | −220 | −477 | −506 | −516 | −516 | −516 | 177 | 196 | −611 | −1 008 | −1 725 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 359 | 434 | 1 220 |
| Short-term debt | 181 | 735 | 560 | 534 | 534 | 534 | 534 | 2 541 | 712 | 1 822 | 1 824 | 1 145 |
| Total debt | 181 | 735 | 560 | 534 | 534 | 534 | 534 | 2 541 | 712 | 2 182 | 2 258 | 2 366 |
EBITDA margin
-34.8%
This company
15.8%
Market median
-320% vs market
20082019
Equity ratio
-269.2%
This company
38.2%
Market median
-805% vs market
20082019
Return on equity
-71657000.0%
This company
18.4%
Market median
-389440317% vs market
20082019
Net profit margin
-35.1%
This company
8.1%
Market median
-533% vs market
20082019
Asset turnover
3.19×
This company
1.12×
Market median
+185% vs market
20082019
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20082019
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DW Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — | |
| Board of Directors | 2017 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOBALANCE LABORATORIES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dennis Wauer | Chief Executive Officer | 0 companies |
| Tor Wauer | Chairman | 0 companies |
| Svein Bolkesjø Bentzen | Board of Directors | 0 companies |